Literature DB >> 10231539

Specific binding of integrin alpha v beta 3 to the fibrinogen gamma and alpha E chain C-terminal domains.

K Yokoyama1, X P Zhang, L Medved, Y Takada.   

Abstract

Integrin alpha v beta 3, a widely distributed fibrinogen receptor, recognizes the RGD572-574 motif in the alpha chain of human fibrinogen. However, this motif is not conserved in other species, nor is it required for alpha v beta 3-mediated fibrin clot retraction, suggesting that fibrinogen may have other alpha v beta 3 binding sites. Fibrinogen has conserved C-terminal domains in its alpha (E variant), beta, and gamma chains (designated alpha EC, beta C, and gamma C, respectively), but their function in cell adhesion is not known, except that alpha IIb beta 3, a platelet fibrinogen receptor, binds to the gamma C HHLGGAKQAGDV400-411 sequence. Here we used mammalian cells expressing recombinant alpha v beta 3 to show that recombinant alpha EC and gamma C domains expressed in bacteria specifically bind to alpha v beta 3. Interaction between alpha v beta 3 and gamma C or alpha EC is blocked by LM609, a function-blocking anti-alpha v beta 3 mAb, and by RGD peptides. alpha v beta 3 does not require the HHLGGAKQAGDV400-411 sequence of gamma C for binding, and alpha EC does not have such a sequence, indicating that the alpha v beta 3 binding sites are distinct from those of alpha IIb beta 3. A small fragment of gamma C (residues 148-226) supports alpha v beta 3 adhesion, suggesting that an alpha v beta 3 binding site is located within the gamma chain 148-226 region. We have reported that the CYDMKTTC sequence of beta 3 is responsible for the ligand specificity of alpha v beta 3. gamma C and alpha EC do not bind to wild-type alpha v beta 1, but do bind to the alpha v beta 1 mutant (alpha v beta 1-3-1), in which the CYDMKTTC sequence of beta 3 is substituted for the corresponding beta 1 sequence CTSEQNC. This suggests that gamma C and alpha EC contain determinants for fibrinogen's specificity to alpha v beta 3. These results suggest that fibrinogen has potentially significant novel alpha v beta 3 binding sites in gamma C and alpha EC.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10231539     DOI: 10.1021/bi9827619

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  25 in total

Review 1.  [New reflections on inflammation and coagulation].

Authors:  K Zacharowski
Journal:  Anaesthesist       Date:  2007-05       Impact factor: 1.041

2.  The interaction of integrin αIIbβ3 with fibrin occurs through multiple binding sites in the αIIb β-propeller domain.

Authors:  Nataly P Podolnikova; Sergiy Yakovlev; Valentin P Yakubenko; Xu Wang; Oleg V Gorkun; Tatiana P Ugarova
Journal:  J Biol Chem       Date:  2013-12-12       Impact factor: 5.157

3.  Direct binding of integrin alphavbeta3 to FGF1 plays a role in FGF1 signaling.

Authors:  Seiji Mori; Chun-Yi Wu; Satoshi Yamaji; Jun Saegusa; Biao Shi; Zi Ma; Yasuko Kuwabara; Kit S Lam; R Rivkah Isseroff; Yoko K Takada; Yoshikazu Takada
Journal:  J Biol Chem       Date:  2008-04-25       Impact factor: 5.157

Review 4.  Fibrinogen Is at the Interface of Host Defense and Pathogen Virulence in Staphylococcus aureus Infection.

Authors:  Ya-Ping Ko; Matthew J Flick
Journal:  Semin Thromb Hemost       Date:  2016-04-07       Impact factor: 4.180

5.  Proinflammatory secreted phospholipase A2 type IIA (sPLA-IIA) induces integrin activation through direct binding to a newly identified binding site (site 2) in integrins αvβ3, α4β1, and α5β1.

Authors:  Masaaki Fujita; Kan Zhu; Chitose K Fujita; Min Zhao; Kit S Lam; Mark J Kurth; Yoko K Takada; Yoshikazu Takada
Journal:  J Biol Chem       Date:  2014-11-14       Impact factor: 5.157

6.  Susceptibility to chronic thromboembolic pulmonary hypertension may be conferred by miR-759 via its targeted interaction with polymorphic fibrinogen alpha gene.

Authors:  Zhiyong Chen; Toshiaki Nakajima; Nobuhiro Tanabe; Kunihiko Hinohara; Seiichiro Sakao; Yasunori Kasahara; Koichiro Tatsumi; Yoshinori Inoue; Akinori Kimura
Journal:  Hum Genet       Date:  2010-07-31       Impact factor: 4.132

Review 7.  Fibrin(ogen) and its fragments in the pathophysiology and treatment of myocardial infarction.

Authors:  Kai Zacharowski; Paula Zacharowski; Sonja Reingruber; Peter Petzelbauer
Journal:  J Mol Med (Berl)       Date:  2006-05-06       Impact factor: 4.599

Review 8.  The multifaceted role of fibrinogen in tissue injury and inflammation.

Authors:  James P Luyendyk; Jonathan G Schoenecker; Matthew J Flick
Journal:  Blood       Date:  2018-12-06       Impact factor: 22.113

9.  Integrins αvβ3 and α4β1 act as coreceptors for fractalkine, and the integrin-binding defective mutant of fractalkine is an antagonist of CX3CR1.

Authors:  Masaaki Fujita; Yoko K Takada; Yoshikazu Takada
Journal:  J Immunol       Date:  2012-11-02       Impact factor: 5.422

10.  A novel fragment derived from the beta chain of human fibrinogen, beta43-63, is a potent inhibitor of activated endothelial cells in vitro and in vivo.

Authors:  E Krajewska; C E Lewis; Y-Y Chen; A Welford; S Tazzyman; C A Staton
Journal:  Br J Cancer       Date:  2010-01-12       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.